In the light of all this and of the recent evidence that Th17 cells play a role in immune-mediated control of tumors [38], [39], [40], our results may provide a mechanistic interpretation for the observed coupling of protective antitumor immunity with autoimmunity during IFN-α therapy. This evidence concerns the gene IFNA1 and Autoimmunity.